Thanks to COVID-era discussions, the 2023 coverage of a Delta passenger who had diarrhea in their seat (I cannot imagine), ...

China is entering the annual peak season for acute infectious diarrhea caused by pathogens such as norovirus and rotavirus, ...

The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...

The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...

Health officials in Illinois are warning of a new and unexpected mutation that could make for a "more serious flu season" as ...

Children are vulnerable to various infections due to developing immune systems. Common infections include gastrointestinal, ...

Wilson Middle School in Wyandotte is closed Nov. 19 due to a potential norovirus outbreak, the district said. Here's what to know.

FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.

The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation, according to a Nov. 5 news release. Linzess is the first ...

A farm owner on the Isle of Wight has been fined after an outbreak resulting in more than 250 people being infected with ...

The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for ...